Course Experts: Julia Jandro, PharmD

Course Description: This course equips pharmacists with practical knowledge to optimize the management of adult patients with soft tissue sarcoma (STS). Participants will review clinically relevant sarcoma subtypes, first-line treatment strategies, targeted therapies, and STS-specific agents to support evidence-based therapeutic decision-making.

[DFCI_KEYWORDS] Chronic Lymphocytic Leukemia (CLL), Brutons Tyrosine Kinase (BTK) Inhibitors, Pathophysiology, Prognostic Markers, Genetic Markers, Cytogenetics, Ibrutinib, Acalabrutinib, Zanubrutinib, Pirtobrutinib, Lymphocytes, Lymphadenopathy, Venetoclax, Obinutuzumab, Rituximab, Fludarabine, Bendamustine, Antiplatelet, Anticoagulation, Leukocytosis